FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Ullman

Research Profile

Disorders

Procedures

Concepts & Ideas

Physiology

Disease Progression

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Gil Y Melmed; Amy Moynihan; David T Rubin; R Balfour Sartor; Ronald M Schwartz; Corey A Siegel; Brennan M Spiegel; John I Allen; Robert Cima; Jean-Frederic Colombel; Themistocles Dassopoulos; Lee A Denson; Sharon Dudley-Brown; Andrew Garb; Stephen B Hanauer; Michael D Kappelman; James D Lewis; Isabelle Lynch; Douglas C Wolf; Thomas A Ullman
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
Uma Mahadevan; Jocelyn Miller; David T Rubin; Corey A Siegel; Thomas A Ullman; John F Valentine; Douglas C Wolf; Antoine Cortot; Marla C Dubinsky; Sarah Glover; Scott D Lee; Maria T Abreu
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
Joana Torres; Thomas A Ullman; Alina C Iuga; Joseph A Odin; Guillaume Pineton de Chambrun; David B Sachar; Kenneth Setchell; Stefania Asciutti; Xiuliang Bao; Anli Chen; Benjamin L Cohen; Jean-Frédéric Colombel; H. Rex Gaskins; Noam Harpaz; Steven H Itzkowitz
Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Ullman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gil Y Melmed; Amy Moynihan; David T Rubin; R Balfour Sartor; Ronald M Schwartz; Corey A Siegel; Brennan M Spiegel; John I Allen; Robert Cima; Jean-Frederic Colombel; Themistocles Dassopoulos; Lee A Denson; Sharon Dudley-Brown; Andrew Garb; Stephen B Hanauer; Michael D Kappelman; James D Lewis; Isabelle Lynch; Douglas C Wolf; Thomas A Ullman
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
Inflammatory bowel diseases 2013;19(3):662-8.
2013: Uma Mahadevan; Jocelyn Miller; David T Rubin; Corey A Siegel; Thomas A Ullman; John F Valentine; Douglas C Wolf; Antoine Cortot; Marla C Dubinsky; Sarah Glover; Scott D Lee; Maria T Abreu
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013;11(3):286-92; quiz e24.
2013: Joana Torres; Thomas A Ullman; Alina C Iuga; Joseph A Odin; Guillaume Pineton de Chambrun; David B Sachar; Kenneth Setchell; Stefania Asciutti; Xiuliang Bao; Anli Chen; Benjamin L Cohen; Jean-Frédéric Colombel; H. Rex Gaskins; Noam Harpaz; Steven H Itzkowitz
Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.
Inflammatory bowel diseases 2013;19(2):275-82.
2013: Andrew Tinsley; Arvind J Trindade; Steven Naymagon; David B Sachar; Bruce E Sands; Thomas A Ullman
A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
Journal of clinical gastroenterology 2013;47(1):e1-6.
2012: Mark Lazarev; Simon Lichtiger; James Marion; Daniel H Present; Mark Chapman; Asher Kornbluth; Thomas A Ullman
The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis.
Journal of clinical gastroenterology 2012;46(9):764-7.
2012: Christina Ha; Corey A Siegel; Thomas A Ullman; Asher Kornbluth
Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012;10(9):1002-7; quiz e78.
2012: Arvind J Trindade; Asher Kornbluth; Andrew Tinsley; Thomas A Ullman
The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD.
The American journal of gastroenterology 2012;107(6):951-2; author reply 952.
2012: Robert Goldstone; Noam Harpaz; Steven Itzkowitz; Thomas A Ullman
Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
Inflammatory bowel diseases 2012;18(5):832-7.
2011: Robert Goldstone; Noam Harpaz; Steven Itzkowitz; Thomas A Ullman
Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
Gastrointestinal endoscopy 2011;74(5):1087-93.
2011: Arvind J Trindade; Adam C Ehrlich; Donald E Morisky; Andrew Tinsley; Thomas A Ullman
Current practice and perception of screening for medication adherence in inflammatory bowel disease.
Journal of clinical gastroenterology 2011;45(10):878-82.
2011: Thomas A Ullman; Steven Itzkowitz
Intestinal inflammation and cancer.
Gastroenterology 2011;140(6):1807-16.
2011: Arvind J Trindade; Adam Ehrlich; Asher Kornbluth; Thomas A Ullman
Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence.
Inflammatory bowel diseases 2011;17(2):599-604.
2010: Mark Lazarev; Thomas A Ullman; Wolfgang H Schraut; Kevin Kip; Melissa Saul; Miguel Regueiro
Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center.
Inflammatory bowel diseases 2010;16(5):830-5.
2009: David B Sachar; Eric Lemmer; Christopher Ibrahim; Yair Edden; Thomas A Ullman; Julie Ciardulo; Esther Roth; Adrian J Greenstein; Joel J Bauer
Recurrence patterns after first resection for stricturing or penetrating Crohn's disease.
Inflammatory bowel diseases 2009;15(7):1071-5.
2009: R Y Akhtar; Blair S Lewis; Thomas A Ullman
Mucosal healing of Crohn's disease demonstrated by capsule endoscopy in a woman with obscure gastrointestinal bleeding.
The American journal of gastroenterology 2009;104(4):1065-6.
2009: Thomas A Ullman; Robert Odze; Francis A Farraye
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon.
Inflammatory bowel diseases 2009;15(4):630-8.
2009: Marco M Hefti; David B Chessin; Noam Harpaz; Randolph M Steinhagen; Thomas A Ullman
Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis.
Diseases of the colon and rectum 2009;52(2):193-7.
2008: Thomas A Ullman; Victoria Croog; Noam Harpaz; Sabera Hossain; Asher Kornbluth; Carol Bodian; Steven Itzkowitz
Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(11):1225-30; quiz 1177.
2008: James F Marion; Jerome D Waye; Daniel H Present; Yuriy Israel; Carol Bodian; Noam Harpaz; Mark Chapman; Steven Itzkowitz; Adam F Steinlauf; Maria Abreu; Thomas A Ullman; James Aisenberg; Lloyd Mayer
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
The American journal of gastroenterology 2008;103(9):2342-9.
2008: David T Rubin; Marcia Cruz-Correa; Christoph Gasche; Jeremy R Jass; Gary R Lichtenstein; Elizabeth Montgomery; Robert H Riddell; Matthew D Rutter; Thomas A Ullman; Fernando S Velayos; Steven Itzkowitz
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.
Inflammatory bowel diseases 2008;14(2):265-74.
2007: Roopali Bansal Gupta; Noam Harpaz; Steven Itzkowitz; Sabera Hossain; Sierra Matula; Asher Kornbluth; Carol Bodian; Thomas A Ullman
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.
Gastroenterology 2007;133(4):1099-105; quiz 1340-1.
2007: Thomas A Ullman
Chromoendoscopy should be the standard method and more widely used for cancer surveillance colonoscopy in ulcerative colitis--con.
Inflammatory bowel diseases 2007;13(10):1273-4; discussion 1275-6.
2005: Sierra Matula; Victoria Croog; Steven Itzkowitz; Noam Harpaz; Carol Bodian; Sabera Hossain; Thomas A Ullman
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(10):1015-21.
2005: Thomas A Ullman
Preventing neoplastic progression in ulcerative colitis.
Journal of clinical gastroenterology 2005;39(4 Suppl 2):S66-9.
2004: Steven Itzkowitz; Thomas A Ullman
The world isn't flat.
Gastrointestinal endoscopy 2004;60(3):426-7.
2003: Thomas A Ullman; Victoria Croog; Noam Harpaz; David B Sachar; Steven Itzkowitz
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
Gastroenterology 2003;125(5):1311-9.
2003: Victoria J Croog; Thomas A Ullman; Steven Itzkowitz
Chemoprevention of colorectal cancer in ulcerative colitis.
International journal of colorectal disease 2003;18(5):392-400.
2003: Thomas A Ullman
Patients with low-grade dysplasia should be advised to undergo colectomy.
Inflammatory bowel diseases 2003;9(4):267-9; discussion 273-5.
2002: Thomas A Ullman
Making the grade: should patients with UC and low-grade dysplasia graduate to surgery or be held back?
Inflammatory bowel diseases 2002;8(6):430-1.
2002: Thomas A Ullman; Edward V Loftus; Sanjay Kakar; Lawrence J Burgart; William J Sandborn; William J Tremaine
The fate of low grade dysplasia in ulcerative colitis.
The American journal of gastroenterology 2002;97(4):922-7.
2000: Thomas A Ullman
Markov Polo: finding the costs of Crohn's in an Olmstead County pool.
Inflammatory bowel diseases 2000;6(1):64-5.